Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol. In press.,European Urology

当前位置： X-MOL 学术 › Eur. Urol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol. In press.
European Urology ( IF 25.3 ) Pub Date : 2020-02-06 , DOI: 10.1016/j.eururo.2019.12.014
Aurélie Kamoun ₁ , Aurélien de Reyniès ₁ , Yves Allory ₂ , Gottfrid Sjödahl ₃ , A Gordon Robertson ₄ , Roland Seiler ₅ , Katherine A Hoadley ₆ , Clarice S Groeneveld ₇ , Hikmat Al-Ahmadie ₈ , Woonyoung Choi ₉ , Mauro A A Castro ₁₀ , Jacqueline Fontugne ₂ , Pontus Eriksson ₁₁ , Qianxing Mo ₁₂ , Jordan Kardos ₆ , Alexandre Zlotta ₁₃ , Arndt Hartmann ₁₄ , Colin P Dinney ₁₅ , Joaquim Bellmunt ₁₆ , Thomas Powles ₁₇ , Núria Malats ₁₈ , Keith S Chan ₁₉ , William Y Kim ₂₀ , David J McConkey ₉ , Peter C Black ₂₁ , Lars Dyrskjøt ₂₂ , Mattias Höglund ₁₁ , Seth P Lerner ₂₃ , Francisco X Real ₂₄ , François Radvanyi ₂₅ , Mattias Aine ₂₆ , Isabelle Bernard-Pierrot ₂₅ , Bogdan Czerniak ₂₇ , Ewan A Gibb ₂₈ , Jaegil Kim ₂₉ , David J Kwiatkowski ₃₀ , Thierry Lebret ₃₁ , Fredrik Liedberg ₃ , A Arlene Siefker-Radtke ₃₂ , Nanor Sirab ₃₃ , Ann Taber ₂₂ , John N Weinstein ₃₄

Affiliation

Cartes d'Identité des Tumeurs (CIT) Program, Ligue Nationale Contre le Cancer, Paris, France.
Department of Pathology, Institut Curie, Saint-Cloud, France; Institut Curie, PSL Research University, CNRS, UMR144, Equipe Labellisée Ligue Contre le Cancer, Paris, France.
Division of Urological Research, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden.
Canada's Michael Smith Genome Sciences Center, BC Cancer Agency, Vancouver, BC, Canada.
Department of Urology, Bern University Hospital, Bern, Switzerland.
Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Cartes d'Identité des Tumeurs (CIT) Program, Ligue Nationale Contre le Cancer, Paris, France; Institut Curie, PSL Research University, CNRS, UMR144, Equipe Labellisée Ligue Contre le Cancer, Paris, France; Bioinformatics and Systems Biology Laboratory, Federal University of Paraná, Polytechnic Center, Curitiba, Brazil.
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Johns Hopkins Greenberg Bladder Cancer Institute and Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
Bioinformatics and Systems Biology Laboratory, Federal University of Paraná, Polytechnic Center, Curitiba, Brazil.
Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Division of Urology, Department of Surgery, University of Toronto, Mount Sinai Hospital and University Health Network, Toronto, ON, Canada.
Institute of Pathology, University Erlangen-Nürnberg, Erlangen, Germany.
Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.
Barts Cancer Institute ECMC, Barts Health and the Royal Free NHS Trust, Queen Mary University of London, London, UK.
Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), CIBERONC, Madrid, Spain.
Cedars-Sinai Samuel Oschin Cancer Institute, Los Angeles, CA, USA.
Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre (CNIO), CIBERONC, Madrid, Spain.
Institut Curie, PSL Research University, CNRS, UMR144, Equipe Labellisée Ligue Contre le Cancer, Paris, France.
Division of Molecular Hematology, Department of Laboratory Medicine, Faculty of Medicine, Lund University, Lund, Sweden.
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
GenomeDx Biosciences Inc., Vancouver, BC, Canada.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Department of Urology, University of Versailles-Saint-Quentin-en-Yvelines, Foch Hospital, Suresnes, France.
Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Pathology, Institut Curie Hospital Group, Paris, France.
Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.